It is in the beta-blocker class of drugs
But skin creams and inhalers are also Glaucoma is the leading cause of irreversible visual impairment worldwide 1 and the second most common cause in Europe
injection 5-10 mg given over 5 minutes plus atenolol tablets 50 mg every 12 hours orally on the first study day (the first oral dose administered about 15 minutes after the I
In addition to lowering blood pressure, a beta-blocker side effect is decreased heart rate
Intraocular pressure (IOP) and heart rate were significantly reduced during treatment, and increased after withdrawal of the drug
Steroid-induced glaucoma has been recognized for over 60 years after a report in 1950 of a rise in eye pressure after systemic adrenocorticotrophic hormone (ACTH)
) oral nadolol therapy with twice daily (b
, cardioselective) drug, produced a median overall fall of 5-6 mmHg (range 3-2 to 13-2 mmHg) in the first tonometrised eyes of 7 patients with open-angle glaucoma or ocular hypertension and 1 with closed-angle glaucoma (off any treatment for the whole of the day preceding each test day) after
Photo: James Fanelli, OD
149 While oral atenolol is commonly used to treat systemic hypertension, neither topical nor oral atenolol is in clinical use Glaucoma can be defined as a progressive optic neuropathy that induces optic disc cupping and retinal ganglion cell apoptosis
e
Beta blockers have numerous contraindications and precautions related to pulmonary and cardiovascular diseases, including severe chronic obstructive pulmonary disease (COPD), bronchial asthma, and bradycardia
These are typical glaucoma medications and their potential side effects: Beta blockers: low pulse and blood pressure, shortness of breath, and fatigue
It is in the beta-blocker class of drugs
For many people a combination of medications and laser treatment can safely control eye pressure for years
C
) Search life-sciences literature (Over 39 million articles, preprints and more) Glaucoma treatment works by lowering internal eye pressure
Beta-blockers, as a class of drugs, are primarily used to treat cardiovascular diseases and other conditions
4 It is estimated that approximately 112 million people will be affected by glaucoma by 2040